wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37001902-86745CCB-750D-4E61-9FE9-4ED57810C087
Q37001902-86745CCB-750D-4E61-9FE9-4ED57810C087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37001902-86745CCB-750D-4E61-9FE9-4ED57810C087
Bevacizumab to combat EGFR-TKI resistance in a patient with advanced non-small cell lung cancer harboring an EGFR mutation: A case report.
P2860
Q37001902-86745CCB-750D-4E61-9FE9-4ED57810C087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37001902-86745CCB-750D-4E61-9FE9-4ED57810C087
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92d31ee1abc12e77e2d9428b9feb5bf4ace9af6b
P2860
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.